+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Vestibular Schwannoma Market - Product Thumbnail Image

Vestibular Schwannoma Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Vascular Endothelial Growth Factor A Vegf A Inhibitor Market - Product Thumbnail Image

Vascular Endothelial Growth Factor A Vegf A Inhibitor Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Advanced Pancreatic Cancer Market - Product Thumbnail Image

Advanced Pancreatic Cancer Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Recurrent Or Metastatic Head And Neck Cancer Market - Product Thumbnail Image

Recurrent Or Metastatic Head And Neck Cancer Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Neuroendocrine Tumors Market - Product Thumbnail Image

Neuroendocrine Tumors Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Metastatic Castration Resistant Prostate Cancer Market - Product Thumbnail Image

Metastatic Castration Resistant Prostate Cancer Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Gastric Neuroendocrine Tumors Market - Product Thumbnail Image

Gastric Neuroendocrine Tumors Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Hodgkin's Lymphoma Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Hodgkin's Lymphoma Treatment Market Report and Forecast 2024-2032

  • Report
  • September 2024
  • 250 Pages
  • Global
From
Unresectable Melanoma Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Unresectable Melanoma Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Nonmelanoma Skin Cancer Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Nonmelanoma Skin Cancer Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Melanoma Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Melanoma Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Hepatocellular Carcinoma Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Hepatocellular Carcinoma Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Gallbladder Cancer Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Gallbladder Cancer Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Colorectal Cancer Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Colorectal Cancer Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Cholangiocarcinoma (CCA) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Cholangiocarcinoma (CCA) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Cancer Anorexia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Cancer Anorexia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Brain Cancer Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Brain Cancer Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Waldenstrom's Macroglobulinemia Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Waldenstrom's Macroglobulinemia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more